DJ Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives
bonyf NV / Key word(s): Research Update/Scientific publication Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives 18-Jul-2024 / 09:19 CET/CEST =---------------------------------------------------------------------------------------------------------------------- Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives Ghent (Belgium), 18 July 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production and marketing of oral, denture, orthodontic and wound care products, is excited to highlight the exceptional capabilities of our Research and Development (R&D) team, whose innovative work has brought Olivafix® Gold to the forefront of denture adhesive technology. Olivafix® Gold, currently available in select countries, represents the next generation of denture fixative creams. It is the only product in the world to achieve such remarkable results through extensive R&D. Multiple studies conducted by renowned universities have published extremely positive results, validating our product's effectiveness and safety. The primary objective of this project was to eliminate the use of petroleum derivatives, which constitute approximately 30% of most denture fixatives. We have successfully replaced these components with healthy, organic Extra virgin olive oil. This endeavor took over five years of meticulous research and fine-tuning to perfect the formula we have today. Our CEO, Jean-Pierre Bogaert, expresses immense pride in the team for accomplishing this nearly impossible task. "We are truly the most advanced innovator of denture fixative in the world, and our primary goal has always been to improve the quality of life for our customers," he stated. In addition to eliminating petroleum derivatives, we have completely removed zinc from our formula. This is a significant advancement, as improper use of zinc-containing products has been linked to neurological problems in some cases. The proven safety of this innovative product did not impact its effectiveness; on the contrary, the performance is exceptional, with up to 24 hours* of holding time. *Up to 24 hours for full upper dentures and strong hold for lower dentures. With Olivafix® Gold, we are making significant strides in providing a safer and more effective solution for denture wearers. Currently available in select countries, we plan to expand its availability to other parts of the world soon. For more information, please visit www.bonyf.com or contact us via the Contact Form. bonyf's strengths -- Products with patented formulations -- Produced in Switzerland compliant with stringent international quality regulations -- Proven clinical efficacy -- Commercial presence in 37 countries -- Prospects for solid growth and rapid profitability -- A fast-growing oral and dental care market About bonyf Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care products. bonyf is a forward-thinking company committed to revolutionizing oral care through innovation and research. With a focus on quality and efficacy, bonyf develops cutting-edge products designed to enhance the well-being of individuals worldwide. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown dental valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the fast-growing oral and dental care market. For more information about bonyf and its innovative oral care products, please visit www.bonyf.com. bonyf Jean-Pierre Bogaert investor@bonyf.com
-----------------------------------------------------------------------------------------------------------------------
Dissemination of a Financial Wire News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
Language: English
Issuer: bonyf NV
Doornzelestraat 114 D
9000 Gent
Belgium
Phone: +41 79 412 42 79
E-mail: president@bonyf.com
Internet: www.bonyf.com
ISIN: BE6333353298
EQS News ID: 1948697
End of Announcement - EQS News Service
=------------------------------------------------------------------------------------
1948697 18-Jul-2024 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=349761dc913be97ee7212b0915b05b09
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=92b7e76d59904a1a0b557bc1f77667e4
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=5f9a0aafb52968783013b6245fa50d5c
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1948697&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face
(END) Dow Jones Newswires
July 18, 2024 03:20 ET (07:20 GMT)
© 2024 Dow Jones News
